We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has granted Breakthrough Device designation to Roche’s Elecsys Amyloid Plasma Panel, a minimally invasive test for early diagnosis of Alzheimer’s through blood biomarkers, which could become the first FDA-approved test for this disease. Read More
MedTech Europe is adopting a revised ethics code that says collaborative research projects between devicemakers and nonindustry partners must “be for the benefit of patients or benefit the healthcare organization (HCO) and at least maintain patient care.” Read More